New York AG Settlement with App Developers Serves as a Warning for the Need for Evidence-Backed Commercial Claims

By Chelsea M. Rutherford and Jennifer S. Geetter on April 5, 2017

Posted In Advertising & Marketing, Big Data, Consumer Protection, Data Privacy, Ecommerce, Electronic Contracting, Mobile Apps, Telehealth, Text Messaging

On March 23, 2017, the New York Attorney General’s office announced that it has settled with the developers of three mobile health (mHealth) applications (apps) for, among other things, alleged misleading commercial claims. This settlement highlights for mHealth app developers the importance of systematically gathering sufficient evidence to support their commercial claims.

Read the full article.

Tags: advertising, FDA, Food and Drug Administration, health and wellness applications, marketing, mHealth, mHealth apps, misleading commercial claims, mobile health, New York Attorney General, wearable technology

Chelsea M. Rutherford
Chelsea M. Rutherford focuses her practice on corporate, transactional and regulatory matters affecting a wide range of clients in the health care and life sciences industries. Read Chelsea M. Rutherford's full bio.

Jennifer S. Geetter
Jennifer S. Geetter advises global life sciences, health care and informatics clients on legal issues attendant to biomedical innovation, research compliance, financial relationship management, digital health practices, and global privacy and data security laws. Jennifer represents a broad range of clients. Read Jennifer Geetter's full bio.

New York AG Settlement with App Developers Serves as a Warning for the Need for Evidence-Backed Commercial Claims

Related Posts

BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES

RECENT POSTS